Europe
The research included 63 of 355 new therapeutic drugs and biologics approved by the U.S. FDA between 2009 and 2018. See what is the drug development cost.
AstraZeneca says the overrun is because of the complexity of the construction, inflation and other factors.
Oculis S.A., a clinical-stage biopharmaceutical company whose mission is to develop novel topical treatments for ophthalmic diseases, announced the appointment of Marcia de Souza Lima, M.D., M.I.P.P., as Chief Medical Officer.
Innovative in-vitro models ready-to-use for safety, ADME, and toxicology studies in drug development and food & nutrition research.
Patent adds to company’s robust portfolio covering clinical stage lead development candidate PD01
Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces the following changes to its Officers and Board of Directors.
MorphoSys AG announced that the U.S. Food and Drug Administration accepted filing of MorphoSys’ Biologics License Application and granted priority review for tafasitamab, the Company’s investigational anti-CD19 antibody, under review in combination with lenalidomide for the treatment of relapsed or refractory diffuse large B cell lymphoma.The FDA has set a Prescription Drug User Fee Act goal date of August 30, 2020.
This approval marks the first time in a decade Sanofi has had a wholly-owned cancer drug approved.
Qiagen manufactures diagnostic tests for a variety of diseases including cancer and, currently, the coronavirus that causes COVID-19.
The drugs in question bring in about $200 million annually.
PRESS RELEASES